We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

110 hedge funds and large institutions have $445M invested in Intersect ENT, Inc in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 31 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 31

0% more call options, than puts

Call options by funds: $950K | Put options by funds: $950K

4% less funds holding

Funds holding: 115110 (-5)

11% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 19

16% less capital invested

Capital invested by funds: $528M → $445M (-$82.4M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
110
Holders Change
-5
Holders Change %
-4.35%
% of All Funds
2.93%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
17
Increased
39
Reduced
31
Closed
19
Calls
$950K
Puts
$950K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TDC
101
Thompson Davis & Co
Virginia
$7K
CG
102
Cutler Group
California
$7K +$1.81K +100 +33%
IPC
103
Independent Portfolio Consultants
Florida
$7K +$6.7K +370 New
Bank of Montreal
104
Bank of Montreal
Ontario, Canada
$5K +$4.82K +266 New
MTIP
105
Magee Thomson Investment Partners
California
$4K
Geode Capital Management
106
Geode Capital Management
Massachusetts
$2.45K +$222K +12,240 +10%
PNC Financial Services Group
107
PNC Financial Services Group
Pennsylvania
$2K -$14.6K -806 -88%
Royal Bank of Canada
108
Royal Bank of Canada
Ontario, Canada
$2K -$12.9K -713 -88%
GT
109
Glenmede Trust
Pennsylvania
$1K +$1.29K +71 New
QT
110
Quantbot Technologies
New York
$1K +$1.81K +100 New
CCM
111
Cadian Capital Management
New York
-$2.7M -120,000 Closed
VAM
112
Visium Asset Management
New York
-$2.25M -100,000 Closed
GC
113
Gratus Capital
Georgia
-$1.53M -68,091 Closed
Invesco
114
Invesco
Georgia
-$1.44M -63,766 Closed
Goldman Sachs
115
Goldman Sachs
New York
-$1.43M -63,665 Closed
PVI
116
Pura Vida Investments
New York
-$1.24M -55,000 Closed
CS
117
Credit Suisse
Switzerland
-$881K -39,173 Closed
FAM
118
Fred Alger Management
New York
-$750K -33,350 Closed
DekaBank Deutsche Girozentrale
119
DekaBank Deutsche Girozentrale
Germany
-$378K -16,981 Closed
Squarepoint
120
Squarepoint
New York
-$365K -16,200 Closed
Susquehanna International Group
121
Susquehanna International Group
Pennsylvania
-$239K -10,624 Closed
Millennium Management
122
Millennium Management
New York
-$231K -10,286 Closed
BCM
123
BlueCrest Capital Management
Jersey
-$222K -9,864 Closed
PP
124
Paloma Partners
Connecticut
-$213K -9,485 Closed
CCMH
125
Cornerstone Capital Management Holdings
New York
-$164K -7,300 Closed

XENT Hedge Fund Activity: Q1 2016 in Review

110 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q1 2016, worth a combined $445M — down 16% from $528M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of XENT and 17 opened new positions — a net loss of 2 holders — while 31 trimmed existing stakes and 39 added.

The largest buyer was Federated Hermes, adding an estimated $16.7M. The largest seller was Allianz Asset Management, cutting an estimated $11.5M.

  • 110 institutional investors held Intersect ENT, Inc (XENT) as of Q1 2016, down from 115 in Q4 2015.
  • Funds reported $445M of Intersect ENT, Inc stock for Q1 2016, down 16% quarter-over-quarter.
  • 17 funds opened new Intersect ENT, Inc positions in Q1 2016 and 19 closed out, a net change of -2 holders.
  • The largest Intersect ENT, Inc buyer in Q1 2016 was Federated Hermes, an estimated $16.7M added.
  • The largest Intersect ENT, Inc seller in Q1 2016 was Allianz Asset Management, an estimated $11.5M sold.

Based on aggregated 13F filings for Q1 2016.